Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00922623 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT00922623 is a NA study that has completed, run by Merz North America. The registered enrollment target is 93 participants.
The verdict
NCT00922623, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
This is a study to assess how safe and effective an investigational product, Belotero® is in people with all skin types with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from outside of the nostrils to the edges of the mouth.
Interventions
- DEVICE Belotero®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00922623
The ClinicalTrials.gov registry entry for NCT00922623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Belotero® is the first listed.
NCT00922623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00922623 about?
NCT00922623 is a clinical study titled "Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI". This is a study to assess how safe and effective an investigational product, Belotero® is in people with all skin types with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from outside of the nostrils to the edges of the mouth.
What is the current status of trial NCT00922623?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2009-05. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00922623?
The interventions under investigation include: Belotero® (DEVICE).
Who is sponsoring clinical trial NCT00922623?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.